Kaposiform Hemangioendothelioma: A Study of 33 Cases Emphasizing Its Pathologic, Immunophenotypic, and Biologic Uniqueness from Juvenile Hemangioma

American Journal of Surgical Pathology

Volumn 28, Issue 5, 2004, Pages 559-568

  Lyons, Lisa L ^a   North, Paula E ^b   Mac Moune Lai, Fernand ^d   Stoler, Mark H ^c   Folpe, Andrew L ^a   Weiss, Sharon W ^a,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Angiosarcoma; Cellular hemangioma of infancy; Common hemangioma; Juvenile hemangioma; Kaposi sarcoma; Kaposiform hemangioendothelioma; Kasabach Merritt phenomenon; Lymphangiomatosis

Indexed keywords

ALPHA ACTIN; ANTIGEN; ANTINEOPLASTIC AGENT; CD31 ANTIGEN; CD34 ANTIGEN; CD61 ANTIGEN; FIBRIN; GLUCOSE TRANSPORTER 1; HEMOSIDERIN; INTERFERON; LEWIS Y ANTIGEN; STEROID; TUMOR MARKER; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; BLOOD GROUP LEWIS SYSTEM; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CAPILLARY HEMANGIOMA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HEMANGIOENDOTHELIOMA; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; KAPOSI SARCOMA; KAPOSIFORM HEMANGIOENDOTHELIOMA; KASABACH MERRITT SYNDROME; LYMPHANGIOMATOSIS; MALE; NEWBORN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PERICYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SOFT TISSUE METASTASIS; STEROID THERAPY; THROMBOCYTE ACTIVATION; TUMOR BLOOD FLOW; TUMOR LOCALIZATION;

EID: 2342593354     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200405000-00001     Document Type: Review

References (37)

1. Alessi E, Bertani E, Sala F. Acquired tufted angioma. Am J Dermatopathol. 1986;8:426-429.
2. Allen PW. Three new vascular tumors: tufted angioma, Kaposiform infantile hemangioendothelioma, and proliferative cutaneous angiomatosis. Int J Surg Pathol. 1994;2:63-72.
3. Beaubien ER, Ball NJ, Storwick GS. Kaposiform hemangioendothelioma: a locally aggressive vascular tumor. J Am Acad Dermatol. 1998;38: 799-802.
4. Blei F, Karp N, Rofsky N, et al. Successful multimodal therapy for kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: case report and review of the literature. Pediatr Hematol Oncol. 1998;15:295-305.
5. Botash RJ, Oliphant M, Capaldo G. Imaging of congenital Kaposiform retroperitoneal hemangioendothelioma associated with Kasabach-Merritt syndrome. Clin Imaging. 1996;20:17-20.
6. Chang Y, Cesarman E, Pessin MS, et al. Identification of Herpes-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266:1865-1869.
7. Deb G, Jenkner A, De Sio L, et al. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon. Med Pediatr Oncol. 1997;28:358-361.
8. Ekfors TO, Kujari H, Herva R. Kaposi-like infantile hemangioendothelioma. Am J Surg Pathol. 1993;17:314-316.
9. Enjolras O, Mulliken JB, Wassef M, et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol. 2000;42: 225-235.
10. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr. 1997;130:631-640.
11. Ezekowitz R, Mulliken JB, Folkman J. Interferon alfa-2a for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326:1456-1463.
12. Fukunaga M, Ushigome S, Ishikawa E. Kaposiform haemangioendothelioma associated with Kasabach-Merritt syndrome. Histopathology. 1996;28:281-284.
13. Gaffey MJ, Frierson HF, Weiss LM, et al. Human papillomavirus and Epstein-Barr virus in sinonasal schneiderian papillomas: an in situ hybridization and polymerase chain reaction study. Am J Clin Pathol. 1996;106: 475-482.
14. George M, Singhal SV, Nopper AJ. Successful surgical excision of a complex vascular lesion in an infant with Kasabach-Merritt syndrome. Pediatr Dermatol. 2002;19:340-344.
15. Gianotti P, Gelmetti C, Alessi E. Congenital cutaneous multifocal kaposiform hemangioendothelioma. Am J Dermatopathol. 1999;21:557-561.
16. Hu B, Lachman R, Phillips J, et al. Kasabach-Merritt syndrome associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D. J Pediatr Hematol Oncol. 1998; 20:567-569.
17. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child. 1961;59:1063-1070.
18. Lalaji TA, Haller JO, Burgess RJ. A case of head and neck kaposiform hemangioendothelioma simulating a malignancy on imaging. Pediatr Radiol. 2001;31:876-878.
19. Lam WY, Mac-Moune Lai F, Look CN, et al. Tufted angioma with complete regression. J Cutan Pathol. 1994;21:461-466.
20. Leaute-Labreze C, Bioulac-Sage P, Labbe L, et al. Tufted angioma with platelet trapping syndrome: response to aspirin. Arch Dermatol. 1997; 133:1077-1079.
21. Mac-Moune Lai F, Fai TOK, Choi PCL, et al. Kaposiform hemangioendothelioma: Five patients with cutaneous lesion and long follow-up. Mod Path. 2001;14:1087-1092.
22. McPartlin DW, Ghufoor K, Patel SK, et al. A rare case of cutaneous kaposiform haemangioendothelioma. Int J Clin Pract. 1999;53:562-563.
23. Mendoza AA, Lourdes TS, Sanz CR, Maldorado RR. Histopathology of vascular lesions found in Kasabach-Merritt Syndrome: Review based on 13 Cases. Ped Dev Path. 2000;556-560.
24. Mentzel T, Mazzoleni G, Dei Tos AP, et al. Kaposiform hemangioendothelioma in adults: clinicopathologic and immunohistochemical analysis of three cases. Am J Clin Pathol. 1997;108:450-455.
25. Neidt GW, Greco MA, Wierczorek R, et al. Hemangioma with Kaposi's sarcoma-like features: report of two cases. Pediatr Pathol. 1989;9:567-575.
26. North PE, Waner M, Nizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31:11-22.
27. North PE, Waner, M, Mizeracki, A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placentas. Arch Dermatol. 2001;137:1-12.
28. North PE, Waner M, James CA, et al. Congential non-progressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol. 2001;137:1607-1620.
29. Padilla RS, Orkin M, Rosai J. Acquired 'tufted' angioma (progressive capillary hemangioma): a distinctive clinicopathologic entity related to lobular capillary hemangioma. Am J Dermatopathol. 1987;9:292-300.
30. Sarkar M, Mulliken JB, Kozakewich HP, et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100:1377-1386.
31. Takahashi K, Mulliken JB, Kozakewich H, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994;93:2357-2364.
32. Vin-Christian K, McCalmont TH, Frieden U. Kaposiform hemangioendothelioma: an aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dermatol. 1997;133:1573-1578.
33. th ed. Philadelphia: Mosby-Harcourt Brace, 2001.
34. Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox 1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002;21: 1505-1513.
35. Wilkin JJ, Meier FA, Kornstein MJ. Kaposiform hemangioendothelioma of the thymus. Arch Path Lab Med. 2000;124:1542-1544.
36. Wilson Jones E, Orkin M. Tufted angioma (angioblastoma): a benign progressive angioma, not to be confused with Kaposi's sarcoma or low-grade angiosarcoma. J Am Acad Dermatol. 1989;20:214-225.
37. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol. 1993;17:321-328.